Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
| Status: | Completed |
|---|---|
| Conditions: | Lung Cancer, Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | October 2008 |
| End Date: | October 2014 |
Palliative Care for Quality of Life and Symptom Concerns in Late Stage Lung Cancer
RATIONALE: Palliative care may be more effective than standard care in improving quality of
life and symptoms in patients with lung cancer.
PURPOSE: This clinical trial is studying the effects of palliative care on quality of life
and symptom control in patients with stage IIIB or stage IV non-small cell lung cancer that
cannot be removed by surgery.
life and symptoms in patients with lung cancer.
PURPOSE: This clinical trial is studying the effects of palliative care on quality of life
and symptom control in patients with stage IIIB or stage IV non-small cell lung cancer that
cannot be removed by surgery.
OBJECTIVES:
- To compare the effects of palliative care intervention (PCI) vs standard care on
overall quality of life and psychological distress in patients with unresectable stage
IIIB or IV non-small cell lung cancer.
- To compare symptom control in these patients.
- To compare geriatric assessment outcomes, as measured by OARS Instrumental Activities
of Daily Living, MOS Activities of Daily Living, MOS Social Activities Limitation
Scale, Hospital Anxiety and Depression Scale scores, and Karnofsky performance scale,
in these patients.
- To compare the effects of the PCI vs standard care on resource use.
- To identify subgroups of patients who benefit most from the PCI in relation to
sociodemographic characteristics, treatment factors, and geriatric assessment
predictors at week 12.
OUTLINE: Patients are assigned to 1 of 2 groups.
Group I (usual care): Patients receive standard care.
Group II (palliative care intervention): Patients receive an individualized
interdisciplinary palliative care intervention comprising sessions, focused on physical,
psychological, social, and spiritual well-being, once weekly in weeks 3-6. Patients then
receive 4 follow-up phone calls in weeks 9, 13, 17, and 21.
- To compare the effects of palliative care intervention (PCI) vs standard care on
overall quality of life and psychological distress in patients with unresectable stage
IIIB or IV non-small cell lung cancer.
- To compare symptom control in these patients.
- To compare geriatric assessment outcomes, as measured by OARS Instrumental Activities
of Daily Living, MOS Activities of Daily Living, MOS Social Activities Limitation
Scale, Hospital Anxiety and Depression Scale scores, and Karnofsky performance scale,
in these patients.
- To compare the effects of the PCI vs standard care on resource use.
- To identify subgroups of patients who benefit most from the PCI in relation to
sociodemographic characteristics, treatment factors, and geriatric assessment
predictors at week 12.
OUTLINE: Patients are assigned to 1 of 2 groups.
Group I (usual care): Patients receive standard care.
Group II (palliative care intervention): Patients receive an individualized
interdisciplinary palliative care intervention comprising sessions, focused on physical,
psychological, social, and spiritual well-being, once weekly in weeks 3-6. Patients then
receive 4 follow-up phone calls in weeks 9, 13, 17, and 21.
Criteria:
- Diagnosis of stage IIIb-IV unresectable NSCLC
- Undergoing treatment with chemotherapy, radiation, or combined modalities
- Living within a 50 mile radius of the City of Hope
- No previous cancer within the past 5 years
We found this trial at
1
site
City of Hope Comprehensive Cancer Center City of Hope is a leading research and treatment...
Click here to add this to my saved trials
